Title

Anaplastic Lymphoma Kinase (ALK) Positive Neuroendocrine Tumor of Lung With Favorable Response to Alectinib (ALK Inhibitor).

Document Type

Article

Publication Date

12-26-2022

Publication Title

Clinical lung cancer

Volume

S1525-7304

Issue

22

First Page

00298-4

DOI

10.1016/j.cllc.2022.12.004

ISSN

1938-0690

PubMed ID

36690569

Share

COinS